Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications...

Area of Science:

• Oncology
• Cancer Biology
• Genetics

Background:

• DNA damage is a key driver of cancer development.
• Deficiencies in DNA damage repair (DDR) pathways are common in cancers, creating dependencies that can be targeted therapeutically.
• Pediatric extracranial solid tumors present unique challenges and opportunities for DDR-targeted therapies.

Purpose of the Study:

• To review the DNA damage repair (DDR) apparatus and its role in tumorigenesis.
• To examine current research on exploiting DDR pathway vulnerabilities in pediatric extracranial solid tumors.
• To discuss the potential of DDR inhibitors, alone and in combination, for cancer treatment and immunotherapy.

Main Methods:

• Literature review of DNA damage repair pathways and their therapeutic targeting.
• Assessment of current research on DDR vulnerabilities in pediatric cancers.
• Evaluation of synergistic combinations of DDR inhibitors with chemotherapy and immunotherapy.

Main Results:

• DDR deficiencies create dependencies that can be therapeutically exploited.
• Combinations of DDR inhibitors with chemotherapy and immunotherapy show promise.
• Targeting DDR pathways may enhance tumor immunogenicity and improve responses to immune checkpoint blockade.

Conclusions:

• DDR pathway targeting represents a promising therapeutic avenue for pediatric solid tumors.
• Further research and clinical trials are crucial to validate the efficacy of DDR inhibitors in pediatric oncology.
• Combination strategies and immunomodulatory effects warrant extensive investigation.